Doctor profile · Federal record
Dr. Brenda Watkins, MD
Dermatology Physician (CMS: Dermatology) · Dripping Springs, TX
- NPI 1871904607
- Accepts Medicare
- MIPS 96.0 / 100 · 2023
- 12 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
170 Benney Ln Ste 203
Dripping Springs, TX 78620
(512) 444-7208
fax (512) 444-2277 - Mailing address
-
4419 Frontier Trl Ste 110
Austin, TX 787451567
Credentials & registration
- NPI registered
- May 2014 — 12 yrs on file
- Profile last updated
- April 23, 2019
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #R6934
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871904607. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,421
Distinct HCPCS
10
Medicare allowed
$320,816
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,999 | 394 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 872 | 644 | $87 | |
17000 |
Destruction of precancer skin growth, 1 growth | 713 | 553 | $49 | |
17110 |
Destruction of skin growth, 1-14 growths | 392 | 324 | $106 | |
11102 |
Biopsy of related skin growth, first growth | 347 | 307 | $85 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 301 | 247 | $122 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 257 | 257 | $108 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 115 | 87 | $154 | |
11103 |
Biopsy of related skin growth, each additional growth | 100 | 61 | $48 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 63 | 63 | $160 |
In context: peer comparison
Among 1 peers in Dripping Springs Dermatology Physician, average services per provider: 271. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$861
Transactions
40
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 8 | $150.84 | |
| Regeneron Healthcare Solutions, INC. | 7 | $139.67 | |
| Sanofi-Aventis U.S. LLC | 1 | $99.00 | |
| Leo Pharma INC. | 4 | $95.54 | |
| Novartis Pharmaceuticals Corporation | 5 | $85.48 | |
| Ucb, INC. | 3 | $67.60 | |
| Genzyme Corporation | 3 | $54.70 | |
| Dermavant Sciences, INC. | 3 | $52.79 | |
| Galderma Laboratories, L.P. | 2 | $50.63 | |
| Janssen Biotech, INC. | 2 | $34.76 | |
| Arcutis Biotherapeutics, INC. | 1 | $17.15 | |
| Pfizer INC. | 1 | $13.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
831
Patients
466
Total drug cost
$128,433
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 137 | 91 | $1,347 |
| Clobetasol Propionate | Generic | 131 | 79 | $7,265 |
| Hydrocortisone | Generic | 125 | 99 | $719 |
| Ketoconazole | Generic | 101 | 57 | $1,620 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 46 | 21 | $632 |
| Mupirocin | Generic | 44 | 34 | $271 |
| Doxycycline Monohydrate | Generic | 42 | 25 | $948 |
| Metronidazole | Generic | 40 | 31 | $2,229 |
| Doxycycline Hyclate | Generic | 34 | 0 | $974 |
| Dupixent Pen (Dupilumab) | Brand | 32 | 0 | $110,834 |
Frequently asked questions
What is Dr. Brenda Watkins's medical specialty?
Dr. Brenda Watkins practices Dermatology Physician in Dripping Springs, TX.
Where does Dr. Brenda Watkins practice?
Dr. Brenda Watkins practices at 170 Benney Ln Ste 203, Dripping Springs, TX 78620. Office phone: 5124447208.
What is Dr. Brenda Watkins's NPI?
Dr. Brenda Watkins's National Provider Identifier (NPI) is 1871904607, issued by NPPES.
Does Dr. Brenda Watkins accept Medicare assignment?
Yes. Dr. Brenda Watkins accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brenda Watkins commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.